Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Desensitization of insulin secretion.

Ingo Rustenbeck1

  • 1Institute of Pharmacology and Toxicology, Technical University of Braunschweig, Mendelssohnstr. 1, D-38106, Braunschweig, Germany. i.rustenbeck@tu-bs.de

Biochemical Pharmacology
|July 3, 2002
PubMed
Summary

Desensitization of insulin secretion, a key factor in type 2 diabetes, involves pancreatic beta-cells losing responsiveness to glucose and other stimuli. This commentary explores conflicting theories on its causes, including impaired glucose recognition versus insulin depletion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relevance of the KATP channel function for the basal insulin hypersecretion of islets from female NZO mice.

Journal of the Endocrine Society·2026
Same author

The Amount of Releasable Insulin Depends on Continuous Oxidative Phosphorylation.

Function (Oxford, England)·2025
Same author

Obituary: Arnold Hasselblatt (1929 - 2024).

Naunyn-Schmiedeberg's archives of pharmacology·2025
Same author

The Proton Leak of the Inner Mitochondrial Membrane Is Enlarged in Freshly Isolated Pancreatic Islets.

Biomedicines·2024
Same author

Short-Term Inhibition of Translation by Cycloheximide Concurrently Affects Mitochondrial Function and Insulin Secretion in Islets from Female Mice.

International journal of molecular sciences·2023
Same author

PyCreas: a tool for quantification of localization and distribution of endocrine cell types in the islets of Langerhans.

Frontiers in endocrinology·2023

Area of Science:

  • Endocrinology
  • Cell Biology
  • Metabolic Diseases

Background:

  • Desensitization of insulin secretion is a reversible state where pancreatic beta-cells show reduced responsiveness to stimuli.
  • This phenomenon is implicated in type 2 diabetes development and treatment failure.
  • Stimuli include glucose, fatty acids, and pharmacological agents that cause beta-cell depolarization.

Purpose of the Study:

  • To outline basic concepts and controversial issues in insulin secretion desensitization.
  • To differentiate between functional impairment and insulin depletion as causes of desensitization.
  • To analyze mechanisms of desensitization induced by glucose and pharmacological agents.

Main Methods:

  • Review and commentary on existing research and concepts.

Related Experiment Videos

  • Analysis of opposing theories regarding glucose-induced desensitization.
  • Examination of mechanisms for pharmacological agent-induced desensitization.

    • Main Results:

    • Two main concepts for glucose desensitization: impaired glucose recognition versus beta-cell exhaustion (insulin depletion).
    • Similar dichotomy exists for pharmacological stimuli: decreased insulin content versus altered signal transduction.
    • Tolbutamide may cause desensitization via insulin depletion; phentolamine via abolished Ca2+ influx.

    Conclusions:

    • Desensitization mechanisms vary depending on the stimulus.
    • Both altered signal transduction and reduced insulin availability can contribute to beta-cell desensitization.
    • Understanding these mechanisms is crucial for managing type 2 diabetes and treatment efficacy.